VP, Regulatory Affairs, Controlled Substances Monitoring Program

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well‑being of you and those we serve - we care.

What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow's health today, we want to hear from you.

The VP, Regulatory Affairs, Controlled Substances Monitoring Program (CSMP) will spearhead the development and implementation of McKesson Medical‑Surgical's CSMP during the business's separation from McKesson Corporation and will lead the CSMP program and team as the separation proceeds.

Reporting directly to the SVP, Compliance & Ethics for McKesson Medical‑Surgical, the VP will lead the implementation and ongoing oversight of appropriate controls, procedures, and training to ensure compliance with all DEA and state regulations on controlled substances. This highly visible role will collaborate cross‑functionally to embed controlled substances regulatory requirements into business operations. The ideal candidate has a strong healthcare compliance or legal background (preferably including the controlled substances regulatory environment), a demonstrated track record collaborating with a wide range of stakeholder groups, experience building compliance programs in complex regulatory areas, and strong leadership skills to foster a culture of compliance and accountability across the organization, including with senior leadership and Board of Directors stakeholders.

The VP will also represent the separated Medical‑Surgical business externally with regulators, manufacturers, customers, and industry groups on controlled substances areas.

McKesson Medical‑Surgical (MMS) is a subsidiary and publicly reported segment of the McKesson Corporation. MMS distributes medical‑surgical supplies, pharmaceuticals, diagnostic equipment and supplies, along with other solutions and services to virtually every type of healthcare setting and provider outside of the traditional hospital. These markets – often referred to as Alternate Care or Non‑Acute Care – include physician offices, surgery centers, long‑term care providers, laboratories, home health and hospice agencies, health systems, government facilities and online marketplaces and retailers.

Alternate Care markets are growing rapidly and MMS is proud to be a leader in this space. With a team of approximately 8,000 employees, a network of 15 distribution centers and approximately 900 delivery vehicles, we partner with more than 2,200 leading manufacturers and serve over 200,000 customer accounts across the U.S. Our catalog includes more than 280,000 SKUs of branded and private‑label medical‑surgical products – from bandages to specialty pharmaceuticals and COVID‑19 tests.

McKesson has announced its intent to separate MMS into an independent company – an exciting evolution that builds on MMS's strong foundation and proven leadership in the Alternate Care space. As a standalone company, MMS would be positioned to unlock new opportunities to innovate, grow and lead with even greater agility and focus. We will also continue to be one of the largest medical‑surgical distributors in the U.S., with over $11B in annual sales.

This separation would accelerate our mission and empower us to shape a future defined by customer‑centricity, bold thinking and operational excellence. For job seekers, it’s a unique moment to join a team that’s already making a meaningful impact and leading the way in shaping the future of healthcare delivery in Alternate Care settings – with even greater opportunity ahead as we prepare to become an independent company.

• Program Development and Implementation: Ensure the development and implementation of an effective CSMP program and controls framework for MMS…